Shaik, N., Erba, H. P., Unni, S., Petersohn, S., Westerberg, E., Gorsh, B., … Kroep, S. (2024). Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia. In Blood (Vol. 144, pp. 1509–1509). American Society of Hematology. https://doi.org/10.1182/blood-2024-209799

Shaik, Nishan, Harry P. Erba, Sudhir Unni, Svenja Petersohn, Elizabeth Westerberg, Boris Gorsh, Akash Nahar, Kristy Burns, and Sonja Kroep. “Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia.” In Blood, 144:1509–1509. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-209799.

Shaik N, Erba HP, Unni S, Petersohn S, Westerberg E, Gorsh B, et al. Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia. In: Blood. American Society of Hematology; 2024. p. 1509–1509.

Shaik, Nishan, et al. “Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 1509–1509. Crossref, doi:10.1182/blood-2024-209799.

Shaik N, Erba HP, Unni S, Petersohn S, Westerberg E, Gorsh B, Nahar A, Burns K, Kroep S. Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia. Blood. American Society of Hematology; 2024. p. 1509–1509.